Accustem Sciences ACUT
OTC ACUT
$0.16 -0.06 (-28.89%)
As of: Aug 21, 2026 · 2:06 PM EDT

Accustem Sciences (ACUT) Cash & Equivalents Growth (3y) (2025)

Accustem Sciences (ACUT) Cash & Equivalents Growth (3y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -15.41%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 8.23%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 47.78%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -23.18%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 14.34%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 37.45%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -14.22%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -3.85%
9 Royalty Pharma 27.27 Bn 26.43 Bn - -27.97%
10 Accustem Sciences 2.57 Mn 2.56 Mn - -52.50%

Historic Data

Download Data
DateValue
Sep 30, 2025 -77.89%
Jun 30, 2025 -74.90%
Mar 31, 2025 -77.62%